Skip to search formSkip to main contentSkip to account menu

Licartin

An immunoradioconjugate containing metuximab, an antibody fragment targeting the hepatocellular cancer (HCC)-associated antigen HAb18G/CD147, that is… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
  • Hye-Lim JuS. Ro
  • 2016
  • Corpus ID: 12839264
Over the past few years, de novo lipogenesis has taken central stage in the field of cancer metabolism (1). Large amount of… 
2015
2015
// Chang Liu 1, * , Guo-Jun Zeng 2, * , Bang-Sheng Jia 3 , Jia-Yin Yang 1 , Li Jiang 1 , Hua Du 1 , Wu-Ran Wei 4 , Bing-Wen Zou 5… 
2014
2014
Objective This study aimed to investigate the effect of Licartin on prevention of recurrence of hepatocelluar carcinoma( HCC… 
2013
2013
The aim of the present study was to examine the safety and efficacy of a peripheral intravenous bolus of Licartin for the… 
2013
2013
OBJECTIVE To evaluate the clinical value of iodine[131I] metuximab infusion combined with transcatheter arterial… 
2010
2010
OBJECTIVE To evaluate the adverse reactions of combining Licartin with transcatheter arterial chemoembolization(TACE)in treatment… 
2007
2007
CD147 (basigin, EMMPRIN, neurothelin, M6, HAb18G, etc.), a transmembrane glycoprotein, has a broad expression pattern on various… 
2007
2007
CD147 molecule is reported to be correlated with the malignancy of some cancers; however, it remains unclear whether it is… 
2007
2007
Imaging and biodistribution of Licartin(131I-labeled hepatoma monoclonal antibody HAb18 F(ab')2) were assessed in vivo.Licartin…